• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION JETSTREAM XC ATHERECTOMY CATHETER; CATHETER, PERIPHERAL, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION JETSTREAM XC ATHERECTOMY CATHETER; CATHETER, PERIPHERAL, ATHERECTOMY Back to Search Results
Model Number 45007
Device Problem Mechanical Problem (1384)
Patient Problems Hematoma (1884); Pain (1994); Perforation of Vessels (2135); Cardiac Tamponade (2226); Blood Loss (2597); Vascular Dissection (3160); No Code Available (3191)
Event Date 09/17/2020
Event Type  Injury  
Event Description
It was reported that the device stalled and also caused perforation, dissection, tamponade, hematoma, and blood loss.A jetstream xc catheter, 2.4mm was selected for use to treat 70% stenosed atherosclerosis in the moderately calcified and mildly tortuous popliteal artery.During the procedure, after the device was run for one minute and thirty seconds at 0.5 mm/second, treating a small eccentric plaque lesion, the device stopped working.The device was removed and it was discovered that the vessel was perforated with a large extravasation and required a non-bsc covered stent be placed to contain the bleeding.The cardiac tamponade was treated by using a 5x100 sterling device.This event caused a drop in blood pressure, intramuscular blood loss, pain and hematoma.Post procedure, patient was reported as stable.The issue was ongoing, and the patient was admitted to the hospital beyond the standard of care.
 
Event Description
It was reported that the device caused perforation, dissection, tamponade, hematoma, and blood loss.A jetstream xc catheter, 2.4mm was selected for use to treat atherosclerosis in the popliteal artery.During the procedure, after the device was run for one minute and thirty seconds treating a small eccentric plaque lesion the device stopped working.The device was removed and it was discovered that the vessel was perforated with a large extravasation and required a non-bsc covered stent be placed to contain the bleeding.The cardiac tamponade was treated by using a 5x100 sterling device.This event caused low blood pressure, intramuscular blood loss, pain and hematoma.Post procedure, patient was reported as stable.It was further reported that the cause of the tamponade was vessel rupture due to the jetstream catheter eroding the vessel wall.Due to the vessel perforation, vascular balloon tamponade was performed via balloon angioplasty inflation over the perforation for five minutes to occlude flow and limit vessel bleeding into the popliteal fossa.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JETSTREAM XC ATHERECTOMY CATHETER
Type of Device
CATHETER, PERIPHERAL, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10567877
MDR Text Key207962544
Report Number2134265-2020-13114
Device Sequence Number1
Product Code MCW
Combination Product (y/n)N
PMA/PMN Number
K130637
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/24/2022
Device Model Number45007
Device Catalogue Number45007
Device Lot Number0025252280
Was Device Available for Evaluation? No
Date Manufacturer Received09/30/2020
Patient Sequence Number1
Treatment
BAREWIRE 315CM; BAREWIRE 315CM; NAV6 4-7MM FILTER; NAV6 4-7MM FILTER; BAREWIRE 315CM; NAV6 4-7MM FILTER
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age75 YR
-
-